- Home
- TPCS vs CNTB Comparison
TPCS vs CNTB Comparison
Compare TPCS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- CNTB
- Stock Information
- Founded
- TPCS 1956
- CNTB 2012
- Country
- TPCS United States
- CNTB United States
- Employees
- TPCS N/A
- CNTB N/A
- Industry
- TPCS Metal Fabrications
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- CNTB Health Care
- Exchange
- TPCS Nasdaq
- CNTB Nasdaq
- Market Cap
- TPCS 51.4M
- CNTB 54.4M
- IPO Year
- TPCS N/A
- CNTB 2021
- Fundamental
- Price
- TPCS $5.59
- CNTB $1.90
- Analyst Decision
- TPCS
- CNTB Strong Buy
- Analyst Count
- TPCS 0
- CNTB 2
- Target Price
- TPCS N/A
- CNTB $7.50
- AVG Volume (30 Days)
- TPCS 97.6K
- CNTB 131.0K
- Earning Date
- TPCS 08-21-2025
- CNTB 08-13-2025
- Dividend Yield
- TPCS N/A
- CNTB N/A
- EPS Growth
- TPCS N/A
- CNTB N/A
- EPS
- TPCS N/A
- CNTB N/A
- Revenue
- TPCS $33,424,000.00
- CNTB $1,965,000.00
- Revenue This Year
- TPCS N/A
- CNTB N/A
- Revenue Next Year
- TPCS N/A
- CNTB N/A
- P/E Ratio
- TPCS N/A
- CNTB N/A
- Revenue Growth
- TPCS 3.78
- CNTB N/A
- 52 Week Low
- TPCS $2.05
- CNTB $0.51
- 52 Week High
- TPCS $6.25
- CNTB $2.86
- Technical
- Relative Strength Index (RSI)
- TPCS 61.93
- CNTB 49.17
- Support Level
- TPCS $4.85
- CNTB $1.70
- Resistance Level
- TPCS $5.80
- CNTB $1.92
- Average True Range (ATR)
- TPCS 0.43
- CNTB 0.20
- MACD
- TPCS -0.04
- CNTB -0.05
- Stochastic Oscillator
- TPCS 62.24
- CNTB 26.98
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.